Latest Breaking News On - Oncternal therapeutics - Page 2 : comparemela.com

Oncternal Therapeutics, Inc (NASDAQ:ONCT) Q1 2024 Earnings Call Transcript

Oncternal Therapeutics, Inc (NASDAQ:ONCT) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

Carl byrnesSalim yazjiRichard vincentKemp dolliverRobert burnsJim breitmeyerJames breitmeyerHartaj singhOncternal therapeutics incOppenheimer companyInternational studentsOncternal therapeuticsCall transcript mayFirst quarterChief financialSafe harbor

Oncternal Therapeutics (NASDAQ:ONCT) Receives New Coverage from Analysts at StockNews com

StockNews.com assumed coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Free Report) in a research note published on Friday morning. The firm issued a hold rating on the stock. Separately, HC Wainwright cut their target price on shares of Oncternal Therapeutics from $30.00 to $28.00 and set a buy rating on the stock in a […]

Exchange commissionRichmond brothers incSecurities exchange commissionOncternal therapeutics incOncternal therapeuticsFree reportGet free reportDirector robert james willsOrphan receptorOncternal therapeutics dailyNasdaq onctInitiated coverageStocknews com

Oncternal Therapeutics (ONCT) Scheduled to Post Quarterly Earnings on Thursday

Oncternal Therapeutics (ONCT) Scheduled to Post Quarterly Earnings on Thursday
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Oncternal therapeutics incOncternal therapeuticsGet free reportDirector robert james willsOrphan receptorOncternal therapeutics daily

Oncternal Therapeutics (NASDAQ:ONCT) Earns Hold Rating from Analysts at StockNews com

Oncternal Therapeutics (NASDAQ:ONCT) Earns Hold Rating from Analysts at StockNews com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Oncternal therapeutics company profileRichmond brothers incSecurities exchange commissionOncternal therapeutics incOncternal therapeuticsFree reportGet free reportDirector robert james willsExchange commissionOrphan receptorOncternal therapeutics daily

Oncternal Therapeutics (NASDAQ:ONCT) Now Covered by Analysts at StockNews com

StockNews.com assumed coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Free Report) in a research note issued to investors on Thursday. The firm issued a hold rating on the stock. Separately, HC Wainwright cut their price target on Oncternal Therapeutics from $30.00 to $28.00 and set a buy rating on the stock in a research […]

Oncternal therapeutics incSecurities exchange commissionPasadena private wealthOncternal therapeutics company profileExchange commissionOncternal therapeuticsFree reportTherapeutics trading downGet free reportDirector robert james willsPrivate wealthOrphan receptorOncternal therapeutics dailyNasdaq onctInitiated coverageStocknews com